These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31089932)

  • 41. Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: a case control study.
    Song DK; Lee H; Hong YS; Sung YA
    BMC Endocr Disord; 2019 Dec; 19(1):145. PubMed ID: 31870342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between serum 25-hydroxyvitamin D and antimüllerian hormone levels in a cohort of African-American women.
    Subramanian A; Harmon QE; Bernardi LA; Carnethon MR; Marsh EE; Baird DD; Jukic AMZ
    Fertil Steril; 2024 Apr; 121(4):642-650. PubMed ID: 38145700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI.
    Rogenhofer N; Jeschke U; von Schönfeldt V; Mahner S; Thaler CJ
    Arch Gynecol Obstet; 2022 Jul; 306(1):219-228. PubMed ID: 35220479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic review and meta-analysis of the association between vitamin D and ovarian reserve.
    Karimi E; Arab A; Rafiee M; Amani R
    Sci Rep; 2021 Aug; 11(1):16005. PubMed ID: 34362981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does vitamin D supplementation improve ovarian reserve in women with diminished ovarian reserve and vitamin D deficiency: a before-and-after intervention study.
    Aramesh S; Alifarja T; Jannesar R; Ghaffari P; Vanda R; Bazarganipour F
    BMC Endocr Disord; 2021 Jun; 21(1):126. PubMed ID: 34154571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The association between anti-Müllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females.
    Simpson S; Seifer DB; Shabanova V; Lynn AY; Howe C; Rowe E; Caprio S; Vash-Margita A
    Reprod Biol Endocrinol; 2020 Nov; 18(1):118. PubMed ID: 33218348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Comprehensive Overview of Common Polymorphic Variants in Genes Related to Polycystic Ovary Syndrome.
    Castillo-Higuera T; Alarcón-Granados MC; Marin-Suarez J; Moreno-Ortiz H; Esteban-Pérez CI; Ferrebuz-Cardozo AJ; Forero-Castro M; Camargo-Vill Alba G
    Reprod Sci; 2021 Sep; 28(9):2399-2412. PubMed ID: 33174186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Association between Vitamin D and Anti-Müllerian Hormone: A Systematic Review and Meta-Analysis.
    Moridi I; Chen A; Tal O; Tal R
    Nutrients; 2020 May; 12(6):. PubMed ID: 32481491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome.
    Mesinovic J; Teede HJ; Shorakae S; Lambert GW; Lambert EA; Naderpoor N; de Courten B
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32357490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin D Levels in Women with Polycystic Ovary Syndrome: A Population-Based Study.
    Lumme J; Sebert S; Pesonen P; Piltonen T; Järvelin MR; Herzig KH; Auvinen J; Ojaniemi M; Niinimäki M
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
    Köstner K; Denzer N; Müller CS; Klein R; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3511-36. PubMed ID: 19667145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations of Polymorphisms in Anti-Müllerian Hormone (AMH Ile49Ser) and its Type II Receptor (AMHRII -482 A>G) on Reproductive Outcomes and Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis.
    Pabalan N; Montagna E; Singian E; Tabangay L; Jarjanazi H; Barbosa CP; Bianco B
    Cell Physiol Biochem; 2016; 39(6):2249-2261. PubMed ID: 27832628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-Müllerian hormone level is associated with vitamin D receptor polymorphisms in women with polycystic ovary syndrome.
    Szafarowska M; Dziech E; Kaleta B; Kniotek M; Rogowski A; Segiet-Święcicka A; Jerzak M
    J Assist Reprod Genet; 2019 Jun; 36(6):1281-1289. PubMed ID: 31089932
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased frequency of the anti-mullerian-inhibiting hormone receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels.
    Georgopoulos NA; Karagiannidou E; Koika V; Roupas ND; Armeni A; Marioli D; Papadakis E; Welt CK; Panidis D
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1866-70. PubMed ID: 23969185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A functional anti-mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients.
    Kevenaar ME; Laven JS; Fong SL; Uitterlinden AG; de Jong FH; Themmen AP; Visser JA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1310-6. PubMed ID: 18230658
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.